跳至主要内容
临床试验/NCT00969982
NCT00969982已完成不适用

Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial

Gynuity Health Projects2 个研究点 分布在 2 个国家目标入组 238 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
238
试验地点
2
主要终点
Rate of successful abortion: defined as complete evacuation using study drug without recourse to any additional intervention.

研究概览

简要总结

The primary goal of this study is to determine the clinical advantage of pre-treatment with mifepristone in second trimester misoprostol induction abortion. This will be a randomized controlled double-blinded trial of 120 women in each country comparing misoprostol alone to mifepristone plus misoprostol for second trimester (14-21 weeks' LMP) medical abortion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
Female
接受健康志愿者

入选标准

  • 14 to 21 weeks gestation, based on menstrual history and clinical exam (with or without ultrasound)
  • Meet legal criteria to obtain abortion
  • Present with closed cervical os and no vaginal bleeding
  • Live fetus at time of presentation for service
  • Have no contraindications to study procedures, according to provider
  • Be able to consent to procedure, either by reading consent document or by having consent document read to her
  • Be willing to follow study procedures

排除标准

  • Known previous transmural uterine incision
  • Known allergy to mifepristone or misoprostol/prostaglandin or other contraindications to the use of mifepristone or misoprostol
  • Any contraindications to vaginal delivery, including placenta previa
  • Presentation in active labor (defined as moderate to severe contractions every 10 minutes or less)

研究组 & 干预措施

mifepristone+misoprostol

Experimental

200 mg mifepristone followed by 800 mcg buccal misoprostol repeated every 3 hours until complete abortion or maximum of 10 doses within 48 hours (maximum 5 doses per 24 hours).

干预措施: mifepristone+misoprostol (Drug)

misoprostol

Active Comparator

Placebo resembling mifepristone followed 24 hours later by 800 mcg buccal misoprostol repeated every 3 hours until complete abortion up to a maximum of 10 doses within 48 hours (maximum 5 doses per 24 hours).

干预措施: misoprostol+placebo (Drug)

结局指标

主要结局

Rate of successful abortion: defined as complete evacuation using study drug without recourse to any additional intervention.

时间窗: 48 hours

Induction-to-abortion interval: defined as time elapsed between administration of the first misoprostol dose until expulsion of the fetus.

时间窗: 48 hours

次要结局

  • Any heavy bleeding, uterine rupture, or infection requiring additional treatment(start of treatment until discharge)
  • Total dose of misoprostol.(Assessed at time of complete abortion with study drug alone or when total maximum dose given.)
  • Provision of additional interventions to manage excessive blood loss(from start of treatment until discharge)
  • Pain experienced by the woman as self-reported.(Assessed during exit interview.)
  • Women's acceptability of the assigned method(Assessed at exit interview)

研究者

发起方
Gynuity Health Projects
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验